rs141122553
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_006267.5(RANBP2):c.1718C>G(p.Ala573Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000138 in 1,611,862 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006267.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152182Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000917 AC: 23AN: 250728Hom.: 0 AF XY: 0.0000884 AC XY: 12AN XY: 135690
GnomAD4 exome AF: 0.000135 AC: 197AN: 1459680Hom.: 0 Cov.: 33 AF XY: 0.000125 AC XY: 91AN XY: 726146
GnomAD4 genome AF: 0.000171 AC: 26AN: 152182Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 8AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1718C>G (p.A573G) alteration is located in exon 12 (coding exon 12) of the RANBP2 gene. This alteration results from a C to G substitution at nucleotide position 1718, causing the alanine (A) at amino acid position 573 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Familial acute necrotizing encephalopathy Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 573 of the RANBP2 protein (p.Ala573Gly). This variant is present in population databases (rs141122553, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with RANBP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 469429). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at